BB Biotech AG
BB Biotech AG (BION.SW) Stock Competitors & Peer Comparison
See (BION.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BION.SW | CHF 32.40 | -2.70% | 1.8B | -4.17 | -CHF 7.77 | +5.56% |
| MOR.SW | CHF 102.00 | +0.00% | 2.4B | -4.03 | -CHF 25.33 | N/A |
| KURN.SW | CHF 27.68 | -7.86% | 1.1B | -276.80 | -CHF 0.10 | N/A |
| BSLN.SW | CHF 55.70 | -3.97% | 683.6M | 9.55 | CHF 5.83 | N/A |
| IDIA.SW | CHF 3.26 | -6.59% | 665.5M | -2.41 | -CHF 1.35 | N/A |
| SANN.SW | CHF 14.10 | -5.37% | 182.3M | -3.82 | -CHF 3.69 | N/A |
| NWRN.SW | CHF 6.83 | -0.87% | 136.3M | 8.65 | CHF 0.79 | N/A |
| MOLN.SW | CHF 2.98 | -2.30% | 109.7M | -1.75 | -CHF 1.70 | N/A |
| RLF.SW | CHF 2.53 | -3.07% | 31.8M | -1.85 | -CHF 1.37 | N/A |
| ADXN.SW | CHF 0.06 | -3.39% | 10.5M | -1.14 | -CHF 0.05 | N/A |
Stock Comparison
BION.SW vs MOR.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, MOR.SW has a market cap of 2.4B. Regarding current trading prices, BION.SW is priced at CHF 32.40, while MOR.SW trades at CHF 102.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas MOR.SW's P/E ratio is -4.03. In terms of profitability, BION.SW's ROE is +0.03%, compared to MOR.SW's ROE of +2.47%. Regarding short-term risk, Volatility data is not available for a full comparison. BION.SW has daily volatility of 1.86 and MOR.SW has daily volatility of N/A.Check MOR.SW's competition here
BION.SW vs KURN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, KURN.SW has a market cap of 1.1B. Regarding current trading prices, BION.SW is priced at CHF 32.40, while KURN.SW trades at CHF 27.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas KURN.SW's P/E ratio is -276.80. In terms of profitability, BION.SW's ROE is +0.03%, compared to KURN.SW's ROE of -0.07%. Regarding short-term risk, BION.SW is less volatile compared to KURN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check KURN.SW's competition here
BION.SW vs BSLN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, BSLN.SW has a market cap of 683.6M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while BSLN.SW trades at CHF 55.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas BSLN.SW's P/E ratio is 9.55. In terms of profitability, BION.SW's ROE is +0.03%, compared to BSLN.SW's ROE of +1.59%. Regarding short-term risk, BION.SW is less volatile compared to BSLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check BSLN.SW's competition here
BION.SW vs IDIA.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, IDIA.SW has a market cap of 665.5M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while IDIA.SW trades at CHF 3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas IDIA.SW's P/E ratio is -2.41. In terms of profitability, BION.SW's ROE is +0.03%, compared to IDIA.SW's ROE of +0.20%. Regarding short-term risk, BION.SW is less volatile compared to IDIA.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check IDIA.SW's competition here
BION.SW vs SANN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, SANN.SW has a market cap of 182.3M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while SANN.SW trades at CHF 14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas SANN.SW's P/E ratio is -3.82. In terms of profitability, BION.SW's ROE is +0.03%, compared to SANN.SW's ROE of -1.11%. Regarding short-term risk, BION.SW is less volatile compared to SANN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check SANN.SW's competition here
BION.SW vs NWRN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, NWRN.SW has a market cap of 136.3M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while NWRN.SW trades at CHF 6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas NWRN.SW's P/E ratio is 8.65. In terms of profitability, BION.SW's ROE is +0.03%, compared to NWRN.SW's ROE of +1.28%. Regarding short-term risk, BION.SW is less volatile compared to NWRN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check NWRN.SW's competition here
BION.SW vs MOLN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, MOLN.SW has a market cap of 109.7M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while MOLN.SW trades at CHF 2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas MOLN.SW's P/E ratio is -1.75. In terms of profitability, BION.SW's ROE is +0.03%, compared to MOLN.SW's ROE of -0.42%. Regarding short-term risk, BION.SW is less volatile compared to MOLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check MOLN.SW's competition here
BION.SW vs RLF.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, RLF.SW has a market cap of 31.8M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while RLF.SW trades at CHF 2.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas RLF.SW's P/E ratio is -1.85. In terms of profitability, BION.SW's ROE is +0.03%, compared to RLF.SW's ROE of -0.40%. Regarding short-term risk, BION.SW is less volatile compared to RLF.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check RLF.SW's competition here
BION.SW vs ADXN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, ADXN.SW has a market cap of 10.5M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while ADXN.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas ADXN.SW's P/E ratio is -1.14. In terms of profitability, BION.SW's ROE is +0.03%, compared to ADXN.SW's ROE of +0.83%. Regarding short-term risk, BION.SW is less volatile compared to ADXN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check ADXN.SW's competition here
BION.SW vs EVE.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, EVE.SW has a market cap of 7.5M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while EVE.SW trades at CHF 1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas EVE.SW's P/E ratio is 7.46. In terms of profitability, BION.SW's ROE is +0.03%, compared to EVE.SW's ROE of +0.13%. Regarding short-term risk, BION.SW is more volatile compared to EVE.SW. This indicates potentially higher risk in terms of short-term price fluctuations for BION.SW.Check EVE.SW's competition here
BION.SW vs SPEX.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, SPEX.SW has a market cap of 3.9M. Regarding current trading prices, BION.SW is priced at CHF 32.40, while SPEX.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas SPEX.SW's P/E ratio is -0.15. In terms of profitability, BION.SW's ROE is +0.03%, compared to SPEX.SW's ROE of N/A. Regarding short-term risk, BION.SW is less volatile compared to SPEX.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check SPEX.SW's competition here
BION.SW vs OBSN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, OBSN.SW has a market cap of 140.6K. Regarding current trading prices, BION.SW is priced at CHF 32.40, while OBSN.SW trades at CHF 0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas OBSN.SW's P/E ratio is -0.00. In terms of profitability, BION.SW's ROE is +0.03%, compared to OBSN.SW's ROE of -1.46%. Regarding short-term risk, BION.SW is less volatile compared to OBSN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check OBSN.SW's competition here
BION.SW vs POLN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, POLN.SW has a market cap of 0. Regarding current trading prices, BION.SW is priced at CHF 32.40, while POLN.SW trades at CHF 1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas POLN.SW's P/E ratio is -0.46. In terms of profitability, BION.SW's ROE is +0.03%, compared to POLN.SW's ROE of -1.32%. Regarding short-term risk, BION.SW is less volatile compared to POLN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check POLN.SW's competition here
BION.SW vs GILD.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, GILD.SW has a market cap of 0. Regarding current trading prices, BION.SW is priced at CHF 32.40, while GILD.SW trades at CHF 66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas GILD.SW's P/E ratio is N/A. In terms of profitability, BION.SW's ROE is +0.03%, compared to GILD.SW's ROE of +0.32%. Regarding short-term risk, BION.SW is more volatile compared to GILD.SW. This indicates potentially higher risk in terms of short-term price fluctuations for BION.SW.Check GILD.SW's competition here
BION.SW vs SKIN.SW Comparison August 2025
BION.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BION.SW stands at 1.8B. In comparison, SKIN.SW has a market cap of 0. Regarding current trading prices, BION.SW is priced at CHF 32.40, while SKIN.SW trades at CHF 35.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BION.SW currently has a P/E ratio of -4.17, whereas SKIN.SW's P/E ratio is -28.13. In terms of profitability, BION.SW's ROE is +0.03%, compared to SKIN.SW's ROE of -1.27%. Regarding short-term risk, BION.SW is less volatile compared to SKIN.SW. This indicates potentially lower risk in terms of short-term price fluctuations for BION.SW.Check SKIN.SW's competition here